Search & Filter

IR Information List

54198 items
Code Company Type Importance Title Date
3281 GLP Investment Corporation Personnel Notice Regarding Partial Amendment of Articles and Election of Officers Apr 13, 2026
3281 GLP Investment Corporation Dividend Notice Regarding the Expiration of Distribution Rights Due to Lapse Period Apr 13, 2026
9663 Nagowa Co., Ltd. Strategy Approach and Policy Regarding the Reduction of Investment Unit Apr 13, 2026
8167 Retail Partners Co., Ltd. Share Buyback Notice Regarding the Resolution on the Acquisition of Treasury Stock (Acquisition of Treasury Stock Based on the Provision of Article 459, Paragraph 1 of the Companies Act) Apr 13, 2026
8167 Retail Partners Co., Ltd. Earnings Fiscal Year Ending February 2026 Financial Reference Materials Apr 13, 2026
8167 Retail Partners Co., Ltd. Earnings Fiscal Year Ending February 2026 Financial Summary [Japanese GAAP] (Consolidated) Apr 13, 2026
3132 Macnica Holdings, Inc. Other Frequently Asked Questions and Answers (Q3 FY2026) Apr 13, 2026
9519 Renova, Inc. Earnings Notice of Electricity Sales Volume for March 2026 Apr 13, 2026
8387 The Shikoku Bank, Ltd. Dividend Announcement Regarding Change in Shareholder Return Policy Apr 13, 2026
8387 The Shikoku Bank, Ltd. Strategy Formulation of Medium-Term Management Plan Apr 13, 2026
1419 Tama Home Co., Ltd. Earnings Publication of Q&A Summary Regarding the 3rd Quarter Earnings Presentation (Telephone Conference) for the Fiscal Year Ending May 2026 Apr 13, 2026
3778 Sakura Internet Inc. Other Notice Regarding Receipt of Large Order for Generative AI Apr 13, 2026
4062 Ibiden Co., Ltd. Other Occurrence of Website Issue on Our Corporate Site (First Report) Apr 13, 2026
6330 Toyo Engineering Corporation Other (Correction) Partial Correction Regarding the Notice of Conversion of Class A Preferred Shares to Common Shares Apr 13, 2026
3608 TSI Holdings Co., Ltd. Earnings Full-Year Financial Results Presentation Materials for the Fiscal Year Ending February 2026 Apr 13, 2026
4565 Nexera Pharma Corporation Strategy Announcement of Subject Dosing Start in Phase 2 Trial of NBI-1117570 for Adult Schizophrenia Patients by Partner NeuroCline, Inc. Apr 13, 2026
6289 Giken Ltd. Earnings Financial Results for the Second Quarter of the Fiscal Year Ending August 2026 (Interim) [Japanese GAAP] (Consolidated) Apr 10, 2026
6330 Toyo Engineering Corporation Strategy Notice of Conversion of Class A Preferred Shares into Common Shares Apr 10, 2026
5304 SEC Carbon Ltd. Strategy Notice Regarding Revision of Medium- to Long-Term Management Targets and Medium-Term Management Plan Apr 10, 2026
7609 Daitron Co., Ltd. Share Buyback Notice Regarding Disposal of Treasury Stock as Restricted Shares for Our Employees Apr 10, 2026